The first, an investigational norovirus mRNA vaccine from Moderna (mRNA-1403), safely elicited strong antibody responses in ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

The Centers for Disease Control recommends staying up to date on COVID-19 vaccinations, especially individuals 65 years and older and those more vulnerable to the virus due to weakened immune systems.

For the Pfizer/BioNTech and Moderna vaccines, this means that small changes ... swelling and redness at the injection site; tiredness; headache; muscle pain; chills; and fever.

The Ministry of Health has approved Moderna's updated COVID vaccines, which target the new JN1 variant of the virus.

In other parts of the world, Moderna's vaccine shares the ... times higher in people who received the J&J vaccine compared to the Pfizer-BioNTech injection. The J&J vaccine is a single-dose ...